National Research (NRC)
(Delayed Data from NSDQ)
$22.80 USD
+0.52 (2.33%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $22.78 -0.02 (-0.09%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for National Research Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 149 | 152 | 148 | 134 | 128 |
Cost Of Goods | 56 | 57 | 52 | 49 | 46 |
Gross Profit | 93 | 95 | 96 | 85 | 82 |
Selling & Adminstrative & Depr. & Amort Expenses | 53 | 48 | 45 | 42 | 39 |
Income After Depreciation & Amortization | 40 | 47 | 50 | 43 | 43 |
Non-Operating Income | 1 | -3 | 0 | 1 | 0 |
Interest Expense | 1 | 1 | 2 | 2 | 2 |
Pretax Income | 40 | 43 | 49 | 41 | 41 |
Income Taxes | 9 | 11 | 11 | 4 | 8 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 31 | 32 | 37 | 37 | 32 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 31 | 32 | 37 | 37 | 32 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 46 | 52 | 57 | 50 | 49 |
Depreciation & Amortization (Cash Flow) | 6 | 5 | 6 | 8 | 6 |
Income After Depreciation & Amortization | 40 | 47 | 50 | 43 | 43 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 24.67 | 25.05 | 25.46 | 25.70 | 25.65 |
Diluted EPS Before Non-Recurring Items | 1.25 | 1.27 | 1.46 | 1.45 | 1.26 |
Diluted Net EPS (GAAP) | 1.25 | 1.27 | 1.46 | 1.45 | 1.26 |
Fiscal Year end for National Research Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 35.02 | 35.31 | 38.00 | 37.95 | 36.16 |
Cost Of Goods | 13.42 | 13.86 | 13.79 | 14.63 | 13.31 |
Gross Profit | 21.60 | 21.46 | 24.21 | 23.31 | 22.85 |
SG&A, R&D, and Dept/Amort Expenses | 12.73 | 12.70 | 12.50 | 13.36 | 13.49 |
Income After SG&A, R&D, and Dept/Amort Expenses | 8.87 | 8.76 | 11.71 | 9.95 | 9.36 |
Non-Operating Income | 0.01 | 0.04 | 0.03 | 0.24 | 0.27 |
Interest Expense | 0.56 | 0.61 | 0.27 | 0.16 | 0.19 |
Pretax Income | 8.32 | 8.19 | 11.47 | 10.04 | 9.44 |
Income Taxes | 2.15 | 1.84 | 2.61 | 2.16 | 2.17 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 6.18 | 6.36 | 8.86 | 7.88 | 7.27 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 6.18 | 6.36 | 8.86 | 7.88 | 7.27 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 23.92 | 23.96 | 24.55 | 24.70 | 24.72 |
Diluted EPS Before Non-Recurring Items | 0.26 | 0.27 | 0.36 | 0.32 | 0.29 |
Diluted Net EPS (GAAP) | 0.26 | 0.27 | 0.36 | 0.32 | 0.29 |